(Q47805143)

English

Comparative analysis using a mouse model of the immunogenicity of artificial VLP and attenuated Salmonella strain carrying a DNA-vaccine encoding HIV-1 polyepitope CTL-immunogen

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

Comparative analysis using a mouse model of the immunogenicity of artificial VLP and attenuated Salmonella strain carrying a DNA-vaccine encoding HIV-1 polyepitope CTL-immunogen (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

attenuated vaccine

1 reference

based on heuristic

inferred from title

Alexander A. Ilyichev

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

12

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

author name string

Larisa I Karpenko

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

Nadezhda A Nekrasova

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

Leonid R Lebedev

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

George M Ignatyev

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

Alexander P Agafonov

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

Boris N Zaitsev

7

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

Pavel A Belavin

8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

Sergei V Seregin

9

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

Nadezhda K Danilyuk

10

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

Irina N Babkina

11

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

language of work or name

0 references

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

22

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

13-14

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

1692-1699

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

Next generation DNA vaccines for HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.050

7 January 2021

DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.050

7 January 2021

T lymphocyte responses in HIV-1 infection: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.050

7 January 2021

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.050

7 January 2021

Construction of an artificial immunogen, a candidate DNA vaccine encoding multiple CTL epitopes of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.050

7 January 2021

HIV vaccine strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.050

7 January 2021

Strategies for designing and optimizing new generation vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.050

7 January 2021

Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.050

7 January 2021

An autologous oral DNA vaccine protects against murine melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.050

7 January 2021

Immunogenicity of an HIV-1 gag DNA vaccine carried by attenuated Shigella

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.050

7 January 2021

Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.050

7 January 2021

Atomic force microscope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.050

7 January 2021

Early helper T-cell dysfunction in simian immunodeficiency virus but not in human immunodeficiency virus type-2-infected macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.050

7 January 2021

Quantification of antigen specific CD8+ T cells using an ELISPOT assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.050

7 January 2021

A new generation of HIV vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.050

7 January 2021

T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.050

7 January 2021

Vaccine development against HIV-1: current perspectives and future directions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.050

7 January 2021

Cytotoxic T cell polyepitope vaccines delivered by ISCOMs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.050

7 January 2021

Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.050

7 January 2021

Identifiers

10.1016/J.VACCINE.2003.09.050

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/15068852

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47805143&oldid=2171544983"